Misuse and Dependence on Non-Prescription Codeine Analgesics or Sedative H1 Antihistamines by Adults: A Cross-Sectional Investigation in France

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Roussin, Anne ^a,b   Bouyssi, Annabelle ^a   Pouché, Lucie ^a   Pourcel, Laure ^a   Lapeyre Mestre, Maryse ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b Hopitaux de Toulouse   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; CHLORPHENIRAMINE; CODEINE; DIMENHYDRINATE; DOXYLAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG; OXOMEMAZINE; PARACETAMOL; PHENIRAMINE; PROMETHAZINE; PSYCHOTROPIC AGENT;

ADULT; ANALGESIA; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG INDICATION; DRUG MISUSE; DSM-IV; FEMALE; FRANCE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHARMACY; PREVALENCE; QUESTIONNAIRE; TREATMENT DURATION;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, OPIOID; CODEINE; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PREVALENCE; QUESTIONNAIRES; SELF MEDICATION; SUBSTANCE-RELATED DISORDERS;

EID: 84884893365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076499     Document Type: Article

References (33)

1. Afssaps (2011) Analyse des ventes des médicaments aux officines et aux hôpitaux en France, 1999-2009. Rapport d'expertise, 11ème édition. Available: http://www.ansm.sante.fr/var/ansm_site/storage/original/application/6949f3707b826ada566544613ee8dafe.pdf. Accessed 10 September 2013.
2. AFIPA. Les chiffres du marché de l'automédication en France. Available: http://www.afipa.org/1-afipa-automedication/119-l-automedication-responsable/327-les-chiffres-du-marche-de-l-automedication.aspx. Accessed 10 September 2013.
3. Matheson C, Bond C, Pitcairn J, (2002) Misuse of over-the-counter medicines from community pharmacies: a population survey of Scottish pharmacies. Pharm J 269: 66-68.
4. Pates R, McBride AJ, Li S, Ramadan R, (2002) Misuse of over-the-counter medicines: a survey of community pharmacies in a South Wales health authority. Pharm J 268: 179-182.
5. Hughes GF, McElnay JC, Hughes CM, Mc Kenna P, (1999) Abuse/misuse of non-prescription drugs. Pharm World Sci 21: 251-255.
6. Fleming GF, McElnay JC, Hughes CM, (2004) Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: a pilot study. Pharm World Sci 26: 282-288.
7. Wazaify M, Hughes CM, McElnay JC, (2006) The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Educ Couns 64: 136-141.
8. Orriols L, Gaillard J, Lapeyre-Mestre M, Roussin A, (2009) Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in France. Drug Saf 32: 859-873.
9. American Psychiatric Association (2000) DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision. Washington DC: American Psychiatric Association.
10. Meolie AL, Rosen C, Kristo D, Kohrman M, Gooneratne N, et al. (2005) Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J Clin Sleep Med 1: 173-187.
11. Morin AK, Jarvis CI, Lynch AM, (2007) Therapeutic options for sleep-maintenance and sleep-onset insomnia. Pharmacotherapy 27: 89-110.
12. No authors listed, (2008) Sleep complaints: Whenever possible, avoid the use of sleeping pills. Prescrire Int 97: 206-212.
13. Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T, (2002) Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol 22: 511-515.
14. Schadeck B, Chelly M, Ansellem D, Cohen A, Peraudeau P, et al. (1996) Comparative efficacy of doxylamine (15 mg) and zolpidem (10 mg) for the treatment of common insomnia: a placebo-controlled study. La Semaine des hôpitaux de Paris 72: 428-439 (article in French).
15. Craig DF, Mellor CS, (1990) Dimenhydrinate dependence and withdrawal. CMAJ 142: 970-973.
16. Thomas A, Nallur DG, Jones N, Deslandes PN, (2009) Diphenhydramine abuse and detoxification: a brief review and case report. J Psychopharmacol 23: 101-105.
17. Gracious B, Abe N, Sundberg J, (2010) The importance of taking a history of over-the-counter medication use: a brief review and case illustration of "PRN" antihistamine dependence in a hospitalized adolescent. J Child Adolesc Psychopharmacol 20: 521-524.
18. Gauvin DV, Carl KL, Briscoe RJ, Vallett M, Holloway FA, (1995) Cross-generalization between a cocaine cue and two antihistamines. Eur J Pharmacol 294: 281-288.
19. Vallejo R, Barkin RL, Wang VC, (2011) Pharmacology of opioids in the treatment of chronic pain syndromes. Pain Physician 14: E343-360.
20. Skurtveit S, Furu K, Borchgrevink P, Handal M, Fredheim O, (2011) To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use? Pain 152: 1555-1561.
21. Frei MY, Nielsen S, Dobbin MD, Tobin CL, (2010) Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust 193: 294-296.
22. McDonough MA, (2011) Misuse of codeine-containing combination analgesics. Med J Aust 194: 486.
23. Sinclair HK, Bond CM, Hannaford PC, Grampian Pharmacy Network, (1999) Pharmacovigilance of over-the-counter products based in community pharmacy: a feasible option? Pharmacoepidemiol Drug Saf 8: 479-491.
24. Gonzales R, Brecht ML, Mooney L, Rawson RA, (2011) Prescription and over-the-counter drug treatment admissions to the California public treatment system. J Subst Abuse Treat 40: 224-229.
25. Lusher J, Elander J, Bevan D, Telfer P, Burton B, (2006) Analgesic addiction and pseudoaddiction in painful chronic illness. Clin J Pain 22: 316-324.
26. Orriols L, Delorme B, Gadegbeku B, Tricotel A, Contrand B, et al. (2010) Prescription medicines and the risk of road traffic crashes: a French registry-based study. PLoS Med 7. doi: 10.1371/journal.pmed.1000366.
27. Howard ME, Desai AV, Grunstein RR, Hukins C, Armstrong JG, et al. (2004) Sleepiness, sleep-disordered breathing, and accident risk factors in commercial vehicle drivers. Am J Respir Crit CareMed 170: 1014-1021.
28. Weiler JM, Woodworth G, Watson G, (2000) Drug Effects on Driving Performance. Ann Intern Med 133: 657-658.
29. Djezzar S, Questel F, Burin E, Dally S, (2009) French Network of Centers for Evaluation and Information on Pharmacodependence (2009) Chemical submission: results of 4-year French inquiry. Int J Legal Med 123: 213-219.
30. Kripke DF, Langer RD, Kline LE, (2012) Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open 2: e000850 doi:10.1136/bmjopen-2012-000850.
31. Bendtsen L, Birk S, Kasch H, Aegidius K, Sørensen PS, et al. (2012) Reference programme: Diagnosis and treatment of headache disorders and facial pain. Danish Headache Society. J Headache Pain13Suppl 1: S1-29.
32. Ferrari A, Cicero AF, Bertolini A, Leone S, Pasciullo G, et al. (2006) Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia 26: 187-193.
33. MHRA (No author listed) (2009) Over-the-counter painkillers containing codeine or dihydrocodeine. Drug Safety Update 3: 6. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087912. Accessed 10 Sept 2013.